Skip to main content

Non-pharmacologic treatment

Non-pharmacologic treatment

07-07-2022 | Fatigue | News

Telephone-based intervention improves fatigue in people with RMDs

Telephone-delivered exercise and cognitive behavioral interventions improve fatigue severity and impact versus usual care in people with inflammatory rheumatic diseases, LIFT study data show.

Rituximab and rheumatology practice in the COVID-19 era

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Anifrolumab for the treatment of lupus

Anifrolumab for the treatment of SLE

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

New additions to the Adis Journal Club

Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

ACR Convergence 2021

3–9 November: Keep up with the latest news and interviews from the conference.

Febuxostat and cardiovascular risk in people with gout

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Telemedicine in rheumatology

Telemedicine in rheumatology: COVID-19 and beyond

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Get ready for ACR Convergence 2020

ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

Detailed image of stem cells

01-10-2020 | Systemic sclerosis | News

QoL benefits of stem cell transplantation shown in SSc

Autologous hematopoietic stem cell transplantation leads to early and sustained clinically relevant improvements in health-related quality of life among patients with systemic sclerosis, study findings indicate.

QoL benefits of stem cell transplantation shown in SSc

QoL benefits of stem cell transplantation shown in SSc

Autologous hematopoietic stem cell transplantation leads to early and sustained clinically relevant improvements in health-related quality of life among patients with systemic sclerosis, study findings indicate.

07-05-2020 | Systemic sclerosis | News

Concise self-management hand program effective for SSc patients

Research indicates that a home-based, self-management program that promotes easy hand exercises and gives direction on moisturizing and warming effectively reduces pain and improves function in the hands of patients with systemic sclerosis.

Multidisciplinary approach needed for rheumatology patients with coronary artery disease

Multidisciplinary approach needed for rheumatology patients with coronary artery disease

An analysis of percutaneous coronary intervention outcomes among people with rheumatic diseases suggests that those with systemic sclerosis have an elevated risk for multiple in-hospital complications, while patients with systemic lupus erythematosus have an increased bleeding risk.

Balloon expandable stent

04-02-2020 | Cardiovascular disease | Highlight | News

Multidisciplinary approach needed for rheumatology patients with coronary artery disease

An analysis of percutaneous coronary intervention outcomes among people with rheumatic diseases suggests that those with systemic sclerosis have an elevated risk for multiple in-hospital complications, while patients with systemic lupus erythematosus have an increased bleeding risk.

03-02-2020 | Systemic lupus erythematosus | News

Upper limb exercises improve QoL in people with SLE

A 12-week program of arm- and hand-strengthening and stretching exercises significantly improves function, dexterity, performance of daily activities, and quality of life in people with systemic lupus erythematosus, research shows.

Haematopoietic stem cells

14-12-2018 | Systemic sclerosis | Case study | Article

A systemic sclerosis patient who has undergone autologous stem cell transplantation

Daniel Furst and Nihal Fathi present a case of a patient with diffuse systemic sclerosis who undergoes autologous hematopoietic stem cell transplantation after failing two other therapies.

A systemic sclerosis patient who has undergone autologous stem cell transplantation

A systemic sclerosis patient who has undergone autologous stem cell transplantation

Daniel Furst and Nihal Fathi present a case of a patient with diffuse systemic sclerosis who undergoes autologous hematopoietic stem cell transplantation after failing two other therapies.

20-11-2018 | Myositis | Article

Long-term follow-up of autologous hematopoietic stem cell transplantation for refractory juvenile dermatomyositis: A case-series study

Zhu J et al. Pediatr Rheumatol 2018; 16: 72. doi: 10.1186/s12969-018-0284-3